Found: 13
Select item for more details and to access through your institution.
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 8, p. 1489, doi. 10.1007/s00432-017-2413-7
- By:
- Publication type:
- Article
Non-reproducible sequence artifacts in FFPE tissue: an experience report.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 7, p. 1199, doi. 10.1007/s00432-017-2399-1
- By:
- Publication type:
- Article
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 4, p. 613, doi. 10.1007/s00432-016-2322-1
- By:
- Publication type:
- Article
T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.
- Published in:
- Seminars in Immunopathology, 2017, v. 39, n. 3, p. 255, doi. 10.1007/s00281-016-0614-9
- By:
- Publication type:
- Article
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
- Published in:
- Scientific Reports, 2016, p. 21678, doi. 10.1038/srep21678
- By:
- Publication type:
- Article
Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031255
- By:
- Publication type:
- Article
Update on the clinical use of kinase inhibitors in melanoma.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2017, v. 15, n. 9, p. 887, doi. 10.1111/ddg.13321
- By:
- Publication type:
- Article
Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim Melanom.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2017, v. 15, n. 9, p. 887, doi. 10.1111/ddg.13321_g
- By:
- Publication type:
- Article
MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 6, p. 983, doi. 10.1007/s00262-019-02341-9
- By:
- Publication type:
- Article
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 3, p. 341, doi. 10.1007/s00262-017-2099-3
- By:
- Publication type:
- Article
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 227, doi. 10.1007/s00262-010-0933-y
- By:
- Publication type:
- Article
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characterization of six Merkel cell polyomavirus‐positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 4, p. 1020, doi. 10.1002/ijc.32280
- By:
- Publication type:
- Article